Covid-19 will not "magically disappear": Why access to widespread testing is paramount

Paul E George; Claire L Stokes; Leda C Bassit; Ann Chahroudi; Janet Figueroa; Mark A Griffiths; Stacy Heilman; David N Ku; Eric J Nehl; Traci Leong; Joshua M Levy; Russell Kempker; Robert G Mannino; Maud Mavigner; Sunita I Park; Anuradha Rao; Paulina A Rebolledo; John D Roback; Beverly B Rogers; Raymond F Schinazi; Julie Sullivan; Erika A Tyburski; Miriam B Vos; Jesse J Waggoner; Yun F Wang; Jen Madsen; Daniel S Wechsler; Clinton H Joiner; Greg S Martin; Wilbur A Lam

doi:10.1002/ajh.26059

Covid-19 will not "magically disappear": Why access to widespread testing is paramount

Am J Hematol. 2021 Feb 1;96(2):174-178. doi: 10.1002/ajh.26059. Epub 2020 Dec 30.

Authors

Paul E George^{1

2}, Claire L Stokes², Leda C Bassit^{2

3

4

5}, Ann Chahroudi^{2

5}, Janet Figueroa^{2

5}, Mark A Griffiths^{2

4}, Stacy Heilman^{2

5}, David N Ku^{5

6}, Eric J Nehl^{5

7

8}, Traci Leong^{5

7}, Joshua M Levy^{2

5}, Russell Kempker^{2

5}, Robert G Mannino^{1

2

5

9}, Maud Mavigner^{2

5

10}, Sunita I Park^{4

5

11}, Anuradha Rao^{2

5}, Paulina A Rebolledo^{2

5

7}, John D Roback^{2

5

12}, Beverly B Rogers^{2

4

5}, Raymond F Schinazi^{2

3

4

5}, Julie Sullivan^{2

5}, Erika A Tyburski^{1

2

5

9}, Miriam B Vos^{2

5

12}, Jesse J Waggoner^{2

5}, Yun F Wang^{2

5}, Jen Madsen¹³, Daniel S Wechsler^{1

2}, Clinton H Joiner^{1

2}, Greg S Martin^{2

5}, Wilbur A Lam^{1

2

5

9}

Affiliations

¹ Aflac Cancer & Blood Disorders Center at Children's Healthcare of Atlanta.
² Emory University School of Medicine.
³ Department of Pediatrics, Laboratory of Biochemical Pharmacology.
⁴ Children's Healthcare of Atlanta.
⁵ The Atlanta Center for Microsystems-Engineered Point-of-Care Technologies.
⁶ Georgia Institute of Technology, GWW School of Mechanical Engineering.
⁷ Emory University Rollins School of Public Health.
⁸ Georgia Clinical & Translational Science Alliance, Atlanta, GA.
⁹ Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology.
¹⁰ Center for Childhood Infections and Vaccines of Children's Healthcare of Atlanta.
¹¹ Emory School of Medicine.
¹² Center for Transfusion and Cellular Therapies.
¹³ MITRE.

No abstract available

Publication types

Research Support, N.I.H., Extramural

MeSH terms

Antigens, Viral / analysis
Antigens, Viral / immunology
COVID-19 / diagnosis*
COVID-19 / epidemiology
COVID-19 Nucleic Acid Testing
COVID-19 Testing* / economics
COVID-19 Testing* / methods
COVID-19 Testing* / statistics & numerical data
Coronavirus Nucleocapsid Proteins / analysis
Coronavirus Nucleocapsid Proteins / immunology
Cost-Benefit Analysis
Evaluation Studies as Topic
Financing, Government
Health Services Accessibility*
Humans
Inventions
National Institutes of Health (U.S.)
Pandemics*
Point-of-Care Testing
Public-Private Sector Partnerships / organization & administration
RNA, Viral / analysis
Reagent Kits, Diagnostic / supply & distribution
SARS-CoV-2 / immunology
SARS-CoV-2 / isolation & purification*
Sensitivity and Specificity
Spike Glycoprotein, Coronavirus / analysis
Spike Glycoprotein, Coronavirus / immunology
United States / epidemiology

Substances

Antigens, Viral
Coronavirus Nucleocapsid Proteins
RNA, Viral
Reagent Kits, Diagnostic
Spike Glycoprotein, Coronavirus
spike protein, SARS-CoV-2

Publication types

MeSH terms

Substances

Grants and funding